Letrozole 25
2.5 mg per tablet
30 tablets per box
Manufacturer: Hilma Biocare
€25.00
-
Worldwide Delivery
-
Payment
Description
Letrozole 2.5mg
Letrozole is a non steroidal aromatase inhibitor also known as Femara. The described profile includes its medical use in hormone sensitive breast cancer and its separate role in estrogen management during anabolic cycles.
Product specifications
Strong suppression of estrogen production
By inhibiting aromatase, Letrozole reduces estrogen formation from aromatizable androgens. Its described profile includes breast tissue changes and water retention where a stronger level of estrogen control is sought, while emphasising the risk of excessive suppression.
- Marked reduction in estrogen production
- Management of gynecomastia related changes
- Reduced fluid retention and bloat
- Free testosterone support described
Usage and administration
The described administration range is 0.25–0.5 mg every other day. It describes adjustment according to bloodwork and symptoms, with low amounts reflecting the compound's strength and the need to avoid an estrogen crash.
Related products and comparisons
Anastrozole and Exemestane are the alternatives named for less intensive estrogen control. Letrozole is presented separately for heavier aromatization or active breast tissue symptoms.
Health and usage information
This page provides educational information about the product to help you make informed choices. It does not replace medical advice. If you have a health condition or questions about dosage, consult a sports medicine doctor or another healthcare professional.
Specification
Overview
Customer Reviews
You may also like
Reviews
There are no reviews yet.